SCHEMBL2401036

SCHEMBL2401036

CC(C)[C@H](N)c1cccc(Br)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
TDO2 P48775 1/20 0.46
MAOA P21397 1/20 0.44
MBTD1 Q05BQ5 1/20 0.43
L3MBTL3 Q96JM7 1/20 0.43
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 1/20 0.41
ADRB1 P08588 1/20 0.40
MIF P14174 1/20 0.40
HTR2A P28223 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR2B P41595 1/20 0.40
GBA1 P04062 1/20 0.38
CYP3A4 P08684 3/20 0.37
CYP2D6 P10635 3/20 0.37
SLC6A2 P23975 3/20 0.37
SLC6A4 P31645 3/20 0.37
SLC6A3 Q01959 3/20 0.37
KCNH2 Q12809 1/20 0.37
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29278100 1.00 IDO1 (0.46) IDO1TDO2MAOAMBTD1L3MBTL3
SCHEMBL30762162 1.00 IDO1 (0.46) IDO1TDO2MAOAMBTD1L3MBTL3
Hydrochloric Acid SCHEMBL30762179 0.98 IDO1 (0.49) IDO1TDO2MAOAMBTD1L3MBTL3
Hydrochloric Acid SCHEMBL17764461 0.98 IDO1 (0.49) IDO1TDO2MAOAMBTD1L3MBTL3
SCHEMBL11080503 0.88 IDO1 (0.46) IDO1TDO2MAOAMBTD1L3MBTL3
SCHEMBL5772657 0.87 IDO1 (0.52) IDO1TDO2MAOAALDH1A1MAPK1
SCHEMBL8061768 0.84 ADRB1 (0.47) ALDH1A1ADRB1MIFHTR2AADRA1A
SCHEMBL14014456 0.83 IDO1 (0.48) IDO1TDO2MAOAMBTD1L3MBTL3
SCHEMBL842088 0.83 IDO1 (0.48) IDO1TDO2MAOAMBTD1L3MBTL3
SCHEMBL3689883 0.83 IDO1 (0.48) IDO1TDO2MAOAMBTD1L3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297112-B1 PYRAZOLE COMPOUNDS AS CCR1 ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2013-04-03 EP disclosed
US-8293917-B2 Pyrazole compounds as CCR1 antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-10-23 US disclosed
US-20110230521-A1 Pyrazole Compounds As CCR1 Antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230521-A1 Pyrazole Compounds As CCR1 Antagonists CCR1, CCR3, CCR4 IDO1 187/4885TDO2 3352/4885MAOA 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.